Sci-Tech News Today
SEE OTHER BRANDS

The latest news on science and technology

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on June 18, 2025

Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery

Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery

WARREN, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today provided an update on its ongoing development of a cytotoxic T lymphocyte (CTL) therapy targeting Epstein-Barr virus (EBV)-associated …

CISO Global Expands CHECKLIGHT Offering with Tailored Packages for PEO Firms and Financial Management Companies

CISO Global Expands CHECKLIGHT Offering with Tailored Packages for PEO Firms and Financial Management Companies

Expanding Addressable Market to $33B Scottsdale, AZ, June 18, 2025 (GLOBE NEWSWIRE) -- CISO Global (NASDAQ: CISO), a leader in AI-powered cybersecurity software and compliance services, announced today the launch of specialized CHECKLIGHT® packages …

Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion

Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Managed Waste Service (“ …

Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA)

Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA)

THE WOODLANDS, Texas, June 18, 2025 (GLOBE NEWSWIRE) --  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that data from a study evaluating the impact of sotagliflozin on hypoglycemia in people with type 1 diabetes will be delivered as an oral …

SaverOne Granted New US Patent Advancing Sensor Fusion Capabilities for Driver Safety

SaverOne Granted New US Patent Advancing Sensor Fusion Capabilities for Driver Safety

This 14th granted patent out of SaverOne’s full IP portfolio of 23 patents and patent applications demonstrates SaverOne’s technological leadership in mobile device detection and classification within vehicles Petah Tikvah, Israel, June 18, 2025 (GLOBE …

IQSTEL and Cycurion (CYCU) Unveil Plans for AI-Powered Next-Generation Cybersecurity Platform, Targeting the Global Telecom Industry

IQSTEL and Cycurion (CYCU) Unveil Plans for AI-Powered Next-Generation Cybersecurity Platform, Targeting the Global Telecom Industry

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Cycurion Inc. (NASDAQ: CYCU), a trusted leader in IT cybersecurity solutions and AI, and IQSTEL Inc. (NASDAQ: IQST), a leading provider of high-tech telecommunications and technology solutions, are pleased to …

Inuvo to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24–25, 2025

Inuvo to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24–25, 2025

LITTLE ROCK, Ark., June 18, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, announced today that it will be participating in the iAccess Alpha Virtual Best Ideas Summer Investment …

IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025

IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025

ASCO 2025 overall survival data bolster IMNN-001’s potential in advanced ovarian cancer, supported by robust translational results at ESMO Results from OVATION 2 Study reinforce IMNN-001 mechanism of action, producing IL-12 and key anti-cancer immune …

TravelPerk launches new medical and baggage insurance add-on to meet the growing need for complete cover when travelling for work

TravelPerk launches new medical and baggage insurance add-on to meet the growing need for complete cover when travelling for work

Nearly half of business travellers (44%) lack an official company travel insurance policy, leaving 24% to rely on personal insurance plans or credit card policies (15%) Business travellers do need the security that insurance provides with 13% of those …

Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025

Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025

- Produced for Pacira by BBC StoryWorks Commercial Productions, The Next Frontier: Mark …

Axient, an Astrion Legacy Company, Selected for $237 Million U.S. Space Force STEP 2.0 Contract to Accelerate Military Space Innovation

Axient, an Astrion Legacy Company, Selected for $237 Million U.S. Space Force STEP 2.0 Contract to Accelerate Military Space Innovation

HUNTSVILLE, Ala., June 18, 2025 (GLOBE NEWSWIRE) -- Astrion, through its legacy company Axient LLC, has been selected by the U.S. Space Force (USSF) as one of 12 awardees on the Space Test Experiments (STEP) 2.0 program. STEP 2.0, a 10-year, multi-award …

Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)

Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)

SOUTH SAN FRANCISCO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

PharmaTher Applauds FDA's New Commissioner’s National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders, and National Security Applications

PharmaTher Applauds FDA's New Commissioner’s National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders, and National Security Applications

TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a company focused on unlocking the pharmaceutical potential of ketamine, today announced its strong support for the U.S. Food …

OTSAW Announces Public Filing of Registration Statement for Proposed Initial Public Offering

OTSAW Announces Public Filing of Registration Statement for Proposed Initial Public Offering

SINGAPORE, June 18, 2025 (GLOBE NEWSWIRE) -- Otsaw Limited (“OTSAW” the “Company”, “we”, “our”) today announced the Company publicly filed a registration statement on Form F-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission …

TruGolf Announces Reverse Stock Split

TruGolf Announces Reverse Stock Split

Salt Lake City, Utah, June 18, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading provider of golf simulator software and hardware, today announced that it filed an amendment to its amended and restated certificate of incorporation …

Aqua Metals Announces 2025 Annual Meeting of Stockholders

Aqua Metals Announces 2025 Annual Meeting of Stockholders

RENO, Nev., June 18, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium-ion battery recycling, today announced it will hold the 2025 Annual Meeting of Stockholders on Tuesday, July 22, 2025, at 7 a.m. PT. The …

Neurona Doses First Patient in Phase 1/2 Trial of NRTX-1001 Cell Therapy in Adults with Drug-Resistant, Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

Neurona Doses First Patient in Phase 1/2 Trial of NRTX-1001 Cell Therapy in Adults with Drug-Resistant, Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

- First patient received bilateral administration of NRTX-1001; no significant surgical complications or adverse events reported to date - - Trial funded by a $14 million grant from California Institute for Regenerative Medicine - - Data from this …

Heramba Electric Announces Board Resolutions and Management Changes Following Extraordinary Shareholder Meeting

Heramba Electric Announces Board Resolutions and Management Changes Following Extraordinary Shareholder Meeting

DÜSSELDORF, Germany and ATLANTA, June 18, 2025 (GLOBE NEWSWIRE) -- Heramba Electric plc (OTC: PITEF) announced today the results of an extraordinary shareholder and board meeting held on June 3, 2025. More than 90.0%+ of shareholders voted on the following …

Driving Innovation in CTE: Upper Bucks County Technical School and Patrick Chrinko Named zSpace School and Educator of Distinction

Driving Innovation in CTE: Upper Bucks County Technical School and Patrick Chrinko Named zSpace School and Educator of Distinction

SAN JOSE, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- zSpace (NASDAQ: ZSPC) (“”zSpace” or the “Company”), a leading provider of augmented and virtual reality solutions for education, today announced that Upper Bucks County Technical School (UBCTS) has been …

Houston American Energy Corp. Announces $2.37 Million Registered Direct Offering

Houston American Energy Corp. Announces $2.37 Million Registered Direct Offering

HOUSTON, TX, June 18, 2025 (GLOBE NEWSWIRE) -- Houston American Energy Corp. (NYSE American: HUSA) (the “Company”) today announced that it has entered into a definitive agreement with an institutional investor (the “SPA”) for the purchase and sale of an …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service